Eli Lilly and Company
Ferring Holding SA
Genentech
Merck & Co.
Novo Nordisk
Pfizer
Sandoz International GmbH
Ipsen
地理的地域による市場細分化では、レポートは次の地域を分析しました-
北米（米国、カナダ、メキシコ）
ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
アジア太平洋（中国、日本、韓国、インド、東南アジア）
南アメリカ（ブラジル、アルゼンチン、コロンビアなど）
中東およびアフリカ（サウジアラビア、アラブ首長国連邦、エジプト、ナイジェリア、南アフリカ）
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL HUMAN GROWTH HORMONE (HGH) INDUSTRY
2.1 Summary about Human Growth Hormone (hGH) Industry
2.2 Human Growth Hormone (hGH) Market Trends
2.2.1 Human Growth Hormone (hGH) Production & Consumption Trends
2.2.2 Human Growth Hormone (hGH) Demand Structure Trends
2.3 Human Growth Hormone (hGH) Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Recombinant Human Growth Hormone (rhGH)
4.2.2 Human Growth Hormone (rhGH)
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Growth Hormone Deficiency
4.3.2 Turner Syndrome
4.3.3 Idiopathic Short Stature
4.3.4 Prader-Willi Syndrome
4.3.5 Small for Gestational Age
4.3.6 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Recombinant Human Growth Hormone (rhGH)
5.2.2 Human Growth Hormone (rhGH)
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Growth Hormone Deficiency
5.3.2 Turner Syndrome
5.3.3 Idiopathic Short Stature
5.3.4 Prader-Willi Syndrome
5.3.5 Small for Gestational Age
5.3.6 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Recombinant Human Growth Hormone (rhGH)
6.2.2 Human Growth Hormone (rhGH)
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Growth Hormone Deficiency
6.3.2 Turner Syndrome
6.3.3 Idiopathic Short Stature
6.3.4 Prader-Willi Syndrome
6.3.5 Small for Gestational Age
6.3.6 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Recombinant Human Growth Hormone (rhGH)
7.2.2 Human Growth Hormone (rhGH)
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Growth Hormone Deficiency
7.3.2 Turner Syndrome
7.3.3 Idiopathic Short Stature
7.3.4 Prader-Willi Syndrome
7.3.5 Small for Gestational Age
7.3.6 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Recombinant Human Growth Hormone (rhGH)
8.2.2 Human Growth Hormone (rhGH)
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Growth Hormone Deficiency
8.3.2 Turner Syndrome
8.3.3 Idiopathic Short Stature
8.3.4 Prader-Willi Syndrome
8.3.5 Small for Gestational Age
8.3.6 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Recombinant Human Growth Hormone (rhGH)
9.2.2 Human Growth Hormone (rhGH)
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Growth Hormone Deficiency
9.3.2 Turner Syndrome
9.3.3 Idiopathic Short Stature
9.3.4 Prader-Willi Syndrome
9.3.5 Small for Gestational Age
9.3.6 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Eli Lilly and Company
10.1.2 Ferring Holding SA
10.1.3 Genentech
10.1.4 Merck & Co.
10.1.5 Novo Nordisk
10.1.6 Pfizer
10.1.7 Sandoz International GmbH
10.1.8 Ipsen
10.2 Human Growth Hormone (hGH) Sales Date of Major Players (2017-2020e)
10.2.1 Eli Lilly and Company
10.2.2 Ferring Holding SA
10.2.3 Genentech
10.2.4 Merck & Co.
10.2.5 Novo Nordisk
10.2.6 Pfizer
10.2.7 Sandoz International GmbH
10.2.8 Ipsen
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
